**
A recent study from Mount Sinai has unveiled concerning findings regarding the exposure of fetuses to PFAS, a group of persistent environmental pollutants known as “forever chemicals.” The analysis of umbilical cord blood has shown that fetuses may be exposed to a far greater number of these compounds than previously recognised, raising significant concerns about the potential health implications for newborns.
Unveiling the Hidden Dangers
Traditionally, examinations of umbilical cord blood have focused on a limited range of common PFAS compounds, such as PFOA and PFOS. However, the innovative approach employed by researchers at Mount Sinai involved a broader, non-targeted analysis. This method tested 120 samples of umbilical cord blood, leading to the identification of 42 distinct PFAS compounds, which had largely gone undetected in earlier assessments.
The study’s co-author, Shelley Liu, an associate professor at the Icahn School of Medicine, emphasised the significance of these findings, stating, “Babies are exposed to many more PFAS than we previously thought. It is particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
This revelation points to a stark reality: the levels of PFAS compounds in fetal blood are likely much higher than previously estimated, potentially impacting the health of future generations.
The Health Risks of PFAS Exposure
PFAS, which encompass approximately 15,000 different substances, are widely used in various products due to their water- and grease-resistant properties. However, they have been linked to serious health issues, including cancer, birth defects, decreased immune response, and other chronic conditions. These chemicals do not naturally degrade, hence their nickname, “forever chemicals.”
A comprehensive review of 40 studies revealed PFAS in 30,000 umbilical cord blood samples, underscoring their pervasive presence. Increased levels of PFAS in pregnant women have been associated with adverse outcomes such as higher infant mortality rates, low birth weight, and long-term obesity issues in children. Additionally, fetal exposure has been linked to a heightened risk of developing cancer, neurological disorders, and cardiovascular diseases later in life.
Regulatory Gaps and the Need for Action
Despite growing evidence of the dangers posed by PFAS, regulatory frameworks have struggled to keep pace with the evolving landscape of these chemicals. The US Environmental Protection Agency (EPA) typically tests for only around 30 to 40 PFAS compounds in water samples, while independent researchers have identified thousands. A previous analysis by The Guardian revealed that regulatory bodies often underestimate PFAS levels in water sources.
The Mount Sinai study contrasted traditional methods with the new non-targeted approach, confirming that comprehensive testing yields a far greater detection of harmful compounds. While the EPA has recently certified a blood test for 53 PFAS compounds, Liu noted that 31 compounds identified in their research were absent from the EPA’s list.
This gap in detection capabilities highlights the urgent need for regulatory reform to ensure better monitoring and protection against these harmful chemicals.
Implications for Future Research
Although the Mount Sinai study did not directly correlate the presence of PFAS in fetal blood with specific health outcomes, Liu acknowledged that elevated levels of these chemicals are generally associated with increased health risks. The blood samples used in the research were part of the federal government’s Home study, which tracks individuals’ exposure to PFAS and associated health consequences over their lifetimes.
David Andrews, acting chief science officer at the Environmental Working Group, commented on the study’s implications, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.” His remarks underline the pressing need for systemic change in how we monitor and regulate these substances.
Why it Matters
The findings of this study serve as a clarion call to both the scientific community and regulatory bodies. As more evidence emerges about the pervasive presence of PFAS in our environment and its potential impact on vulnerable populations, particularly fetuses, it becomes increasingly critical to advocate for stringent health protections. Ignoring these chemicals could lead to a generation of children facing profound health challenges, making it imperative that we act swiftly to safeguard their futures. The health of our children is paramount, and we must ensure they are not born into a world filled with toxic legacies.
